UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases

International journal of molecular sciences, 2022-10, Vol.23 (21), p.13176

2022

Volltextzugriff (PDF)

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists

PloS one, 2022-01, Vol.17 (1), p.e0261843-e0261843

2022

Volltextzugriff (PDF)

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications

Cells (Basel, Switzerland), 2022-10, Vol.11 (20), p.3214

2022

Volltextzugriff (PDF)

Venous thromboembolism in sarcoidosis: Mere comorbidity or catalyst for disease evolution?

Respiratory medicine and research, 2024-06, Vol.85, p.101062, Article 101062

2024

Volltextzugriff (PDF)

Latest advances in the reversal strategies for direct oral anticoagulants

Fundamental & clinical pharmacology, 2024-08, Vol.38 (4), p.674-684

2024

Volltextzugriff (PDF)

Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?

International journal of molecular sciences, 2023-09, Vol.24 (19), p.14433

2023

Volltextzugriff (PDF)

Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study

PloS one, 2019-08, Vol.14 (8), p.e0221534-e0221534

2019

Volltextzugriff (PDF)

Occurrence of Major Local Lower Limb Events in Type 2 Diabetic Patients with Lower Extremity Arterial Disease: Impact of Metformin

Annals of vascular surgery, 2023-03, Vol.90, p.153-161

2023

Volltextzugriff (PDF)

Cardiac Biomarkers in Patients with Acute Pulmonary Embolism

Medicina (Kaunas, Lithuania), 2022-04, Vol.58 (4), p.541

2022

Volltextzugriff (PDF)

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors

Journal of thrombosis and haemostasis, 2024-08, Vol.22 (8), p.2211-2226

2024

Volltextzugriff (PDF)

Do all patients with cancer thrombosis have the same risk of bleeding and recurrence? Particularities of lung cancer

Expert review of respiratory medicine, 2024, Vol.18 (1-2), p.5-7

2024

Volltextzugriff (PDF)

Pulmonary Embolism in the Cancer Associated Thrombosis Landscape

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5650

2022

Volltextzugriff (PDF)

Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?

Respiratory medicine and research, 2024-06, Vol.85, p.101069, Article 101069

2024

Volltextzugriff (PDF)

Evolutionary adaptation of the γ‐carboxyglutamic acid domain in blood coagulation factor X in the Serpentes suborder

The FASEB journal, 2021-05, Vol.35 (S1), p.n/a, Article fasebj.2021.35.S1.02161

2021

Volltextzugriff (PDF)

Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH

Blood reviews, 2024-09, p.101240, Article 101240

2024

Volltextzugriff (PDF)

Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives

Vascular health and risk management, 2022-01, Vol.18, p.359-373

2022

Volltextzugriff (PDF)

Temporary inferior vena cava filters factors associated with non-removal

European radiology, 2023-04, Vol.33 (4), p.2585-2592

2023

Volltextzugriff (PDF)

Evolutionary Adaptations in Pseudonaja Textilis Venom Factor X Induce Zymogen Activity and Resistance to the Intrinsic Tenase Complex

Thrombosis and haemostasis, 2020-11, Vol.120 (11), p.1512-1523

2020

Volltextzugriff (PDF)

Diagnostic Approach for Venous Thromboembolism in Cancer Patients

Cancers, 2023-06, Vol.15 (11), p.3031

2023

Volltextzugriff (PDF)

In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients

Cancers, 2022-04, Vol.14 (8), p.1937

2022

Volltextzugriff (PDF)

Anticoagulation and venous thromboembolism in patients aged 90years and older: Data from the RIETE registry

Journal of the American Geriatrics Society (JAGS), 2024-01, Vol.72 (1), p.113-125

2024

Volltextzugriff (PDF)

Venous thromboembolism in sarcoidosis: Mere comorbidity or catalyst for disease evolution?

Respiratory medicine and research, 2024-06, Vol.85

2024

Volltextzugriff (PDF)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events

Frontiers in cardiovascular medicine, 2023-08, Vol.10, p.1132156-1132156

2023

Volltextzugriff (PDF)

Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study

PloS one, 2019-08, Vol.14 (8)

2019

Volltextzugriff (PDF)

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists

PloS one, 2022-01, Vol.17 (1)

2022

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(33)

Sprache

Englisch
(32)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications

Venous thromboembolism in sarcoidosis: Mere comorbidity or catalyst for disease evolution?

Latest advances in the reversal strategies for direct oral anticoagulants

Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?

Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study

Occurrence of Major Local Lower Limb Events in Type 2 Diabetic Patients with Lower Extremity Arterial Disease: Impact of Metformin

Cardiac Biomarkers in Patients with Acute Pulmonary Embolism

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors

Do all patients with cancer thrombosis have the same risk of bleeding and recurrence? Particularities of lung cancer

Pulmonary Embolism in the Cancer Associated Thrombosis Landscape

Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?

Evolutionary adaptation of the γ‐carboxyglutamic acid domain in blood coagulation factor X in the Serpentes suborder

Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH

Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives

Temporary inferior vena cava filters factors associated with non-removal

Evolutionary Adaptations in Pseudonaja Textilis Venom Factor X Induce Zymogen Activity and Resistance to the Intrinsic Tenase Complex

Diagnostic Approach for Venous Thromboembolism in Cancer Patients

In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients

Anticoagulation and venous thromboembolism in patients aged 90years and older: Data from the RIETE registry

Venous thromboembolism in sarcoidosis: Mere comorbidity or catalyst for disease evolution?

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events

Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists

Suchergebnisse filtern